Tonic-Clonic Seizure Therapeutics Market is Anticipated to Witness High Growth Owing to Increasing Healthcare Spending
Tonic-clonic seizures, also known as grand mal seizures, are characterized by a stiffened body, jerking movements, and loss of consciousness. Tonic-clonic seizures are generally treated with anti-seizure medications such as phenytoin, fosphenytoin, valproate, and carbamazepine. Increasing prevalence of epilepsy and rising investments by pharmaceutical companies to develop novel therapeutics are driving the demand for tonic-clonic seizure therapeutics. The global Tonic-clonic Seizure Market is estimated to be valued at US$4.2 billion in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024-2032.
Key Takeaways
Key players operating in the tonic-clonic seizure therapeutics market are UCB Biosciences, GlaxoSmithKline, Pfizer, Lundbeck, Novartis, Sanofi, AbbVie, and Sunovion. UCB Biosciences is a leader in the market with its blockbuster drug Keppra (levetiracetam) being one of the preferred first-line treatments for tonic-clonic seizures.
There are significant opportunities to develop innovative drug delivery systems such as implantable devices and stem cell therapies. Ongoing clinical trials evaluating the safety and efficacy of cannabidiol and vagus nerve stimulation represent promising therapies.
Global pharmaceutical companies are focusing their efforts on emerging markets in Asia Pacific and Latin America to gain market share. Strategic acquisitions and partnerships with local players will help accelerate their geographic expansion plans in high growth regions.
Market Drivers
Increasing healthcare expenditures in low and middle-income countries is expected to boost the uptake of effective yet affordable generic anti-seizure medications. According to the World Bank, total healthcare spending in developing nations is projected to reach US$1.5 trillion by 2022.
Market Restrains
Stringent regulatory pathways for approval of new drugs and devices can impede market growth.Drug development costs are soaring, with the average costs estimated between US$500 million to $2 billion. This high uncertainty and investment requirements pose challenges.
Segment Analysis
The tonic-clonic seizure market can be segmented into generalized tonic-clonic seizures and focal seizures with impaired awareness. Generalized tonic-clonic seizures dominate the market as they account for about 80% of unprovoked seizures in adults. These seizures involve stiffening of the whole body followed by jerking movements. Witnesses often describe these seizures as convulsions. Focal seizures with impaired awareness are less common as they involve altered behavior or experience without full awareness during seizures. These seizures often begin in one area of the brain and do not affect it entirely.
Global Analysis
Regionally, North America dominates the tonic-clonic seizure market due to high awareness, advanced healthcare infrastructure and presence of major market players. However, Asia Pacific is expected to grow at the fastest rate due to increasing healthcare expenditure, large patient pool and expanding medical tourism industry. Countries like China and India are emerging as lucrative markets. In North America, the US accounts for the largest share owing to supportive insurance policies and availability of advanced treatment options. Meanwhile, Germany, France and the UK lead the European market due to growing R&D investments by pharmaceutical companies and rising research activities for treatment innovations.
Get more insights on this topic : https://justpaste.it/fpej3
What Are The Key Data Covered In This Tonic-clonic Seizure Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Tonic-clonic Seizure's growth between 2024 and 2031.
:- Accurate calculation of the size of the Tonic-clonic Seizure and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Tonic-clonic Seizure Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Tonic-clonic Seizure vendors
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian